Innoviva Inc (INVA)
19.06
-0.09
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
+0.02
(+0.08%)
After-Hours: 20:00
Innoviva Total Liabilities (Quarterly): 563.07M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 563.07M |
| June 30, 2024 | 559.40M |
| March 31, 2024 | 563.93M |
| December 31, 2023 | 568.55M |
| September 30, 2023 | 560.61M |
| June 30, 2023 | 563.15M |
| March 31, 2023 | 568.28M |
| December 31, 2022 | 665.71M |
| September 30, 2022 | 686.34M |
| June 30, 2022 | 572.18M |
| March 31, 2022 | 555.26M |
| December 31, 2021 | 400.46M |
| September 30, 2021 | 395.43M |
| June 30, 2021 | 395.40M |
| March 31, 2021 | 391.61M |
| December 31, 2020 | 391.73M |
| September 30, 2020 | 387.38M |
| June 30, 2020 | 386.81M |
| March 31, 2020 | 382.14M |
| December 31, 2019 | 382.71M |
| September 30, 2019 | 392.19M |
| June 30, 2019 | 395.60M |
| March 31, 2019 | 390.17M |
| December 31, 2018 | 389.14M |
| September 30, 2018 | 385.97M |
| Date | Value |
|---|---|
| June 30, 2018 | 494.06M |
| March 31, 2018 | 489.49M |
| December 31, 2017 | 610.04M |
| September 30, 2017 | 613.93M |
| June 30, 2017 | 668.75M |
| March 31, 2017 | 726.06M |
| December 31, 2016 | 731.99M |
| September 30, 2016 | 738.41M |
| June 30, 2016 | 741.21M |
| March 31, 2016 | 749.80M |
| December 31, 2015 | 751.58M |
| September 30, 2015 | 760.63M |
| June 30, 2015 | 756.08M |
| March 31, 2015 | 748.84M |
| December 31, 2014 | 745.00M |
| September 30, 2014 | 746.85M |
| June 30, 2014 | 793.14M |
| March 31, 2014 | 341.78M |
| December 31, 2013 | 382.13M |
| September 30, 2013 | 335.97M |
| June 30, 2013 | 509.06M |
| March 31, 2013 | 500.01M |
| December 31, 2012 | 213.55M |
| September 30, 2012 | 210.66M |
| June 30, 2012 | 210.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
382.14M
Minimum
Mar 2020
686.34M
Maximum
Sep 2022
497.01M
Average
557.33M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.232B |
| Shareholders Equity (Quarterly) | 668.54M |
| Debt to Equity Ratio | 0.6698 |
| Current Ratio | 1.790 |
| Net Debt Paydown Yield | -0.04% |